article

Drug Target Review – Issue #1 2016

Posted: 17 March 2016 | Drug Target Review | 2 comments

Included in this issue: Microfluidics, Protein Expression, Drug Targets, Biomarkers, Oncology, Assays, Antibodies, and much more…

DTR Issue 1 2016

In Issue #1 2016 of Drug Target Review:

  • FOREWORD: Using computational models to aid drug discovery
    Jon Timmis, Chief Executive Officer, SimOmics Ltd
  • MICROFLUIDICS: The fur-free way towards personalised medicine in cancer therapy
    Amy Dawson,Victoria Green, Ruth Bower and John Greenman, University of Hull
  • PROTEIN EXPRESSION: Pushing the limits of protein expression with miRNAs
    Simon Fischer, Boehringer Ingelheim, and Rene Handrick and Kerstin Otte, Biberach University of Applied Sciences
  • DRUG TARGETS IN-DEPTH FOCUS
    With contributions from Jean-Marie Frère and Sébastien Rigali, Université de Liège, Ken McGarry, Anuam Rashid and Hannah Smith, University of Sunderland, and Sheraz Gul and Maria Kuzikov, Fraunhofer-IME SP
  • BIOMARKERS: Strategies for identifying predictive biomarkers of nonalcoholic fatty liver disease
    Wasco Wruck, Marie-Ann Kawala, Nina Graffmann and James Adjaye, Heinrich-Heine-University
  • ONCOLOGY: Classifying brain tumours to improve diagnoses
    Xiaolong Fan, Beijing Normal University
  • ASSAYS IN-DEPTH FOCUS
    With articles from David Shum, Institut Pasteur Korea, Gabriele Sorg, Hit Discovery Constance and Horst Flotow, Singapore Screening Centre
  • ANTIBODIES IN-DEPTH FOCUS
    With features from Carol Harley, IBMC and i3S, Ricardo S. Vieira-Pires, University of Coimbra and Sukmook Lee, Scripps Korea Antibody Institute

Issue #1 2016 is restricted - login or subscribe free to access

DTR issue 2 2018 coverThank you for visiting our website. To access this content in full you'll need to login. It's completely free to subscribe, and in less than a minute you can continue reading. If you've already subscribed, great - just login.

Why subscribe? Join our growing community of thousands of industry professionals and gain access to:

  • quarterly issues in print and/or digital format
  • case studies, whitepapers, webinars and industry-leading content
  • breaking news and features
  • our extensive online archive of thousands of articles and years of past issues
  • ...And it's all free!

Click here to Subscribe today Login here

 


2 responses to “Drug Target Review – Issue #1 2016”

  1. MAlava says:

    Thanks it is very important this journal

  2. PD Dr Hansjuergen Bondke says:

    Interesting Scientific journal

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Send this to a friend